Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers.

导出 LinkOut

翻译打印收藏纠错

作者： Mehdi,Shafa ^[1] ; Fan,Yang ^[1] ; Thomas,Fellner ^[1] ; Mahendra S,Rao ^[2] ; Behnam Ahmadian,Baghbaderani ^[3]

作者单位： Lonza Walkersville, Inc., Walkersville, MD, United States. ^[1] NxCell Inc, Novato, CA, United States. ^[2] Q Therapeutics, Salt Lake City, UT, United States. ^[3]

关键词 cell therapy current good manufacturing practices differentiation induced pluripotent stem cells regenerative medicine

DOI 10.3389/fmed.2018.00069

PMID 29600249

发布时间 2020-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览5

Frontiers in medicine

2018年5卷

69页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers.

Frontiers in medicine

相似文献

Frontiers in medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers.

Frontiers in medicine

相似文献

Frontiers in medicine

相关期刊

检索历史清除